Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
7 "Synchronous"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Article
Gastrointestinal cancer
Molecular Mosaics: Unveiling Heterogeneity in Synchronous Colorectal Cancers
Hyun Gu Lee, Yeseul Kim, Mi-Ju Kim, Yeon Wook Kim, Sun-Young Jun, Deokhoon Kim, In Ja Park, Seung-Mo Hong
Cancer Res Treat. 2026;58(1):264-274.   Published online February 18, 2025
DOI: https://doi.org/10.4143/crt.2024.947
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Molecular characteristics of synchronous colorectal cancers (SCRCs) remain incompletely elucidated, despite their importance in targeted therapy selection. We compared the molecular characteristics and somatic mutations between SCRCs.
Materials and Methods
This retrospective study (2012-2014) included 98 consecutive patients with surgically resected SCRCs. Molecular characteristics, including microsatellite instability (MSI) and tumor-infiltrating lymphocytes (TILs), were analyzed for all cancer lesions. The intertumoral heterogeneity of SCRCs was evaluated using whole-exome sequencing (WES) for 18 cancers from nine patients with at least one MSI-high (MSI-H) tumor.
Results
Twelve patients had at least one MSI-H tumor; five showed discordant MSI status. Mucinous adenocarcinoma frequency and TIL density were higher in patients with at least one MSI-H tumor than in those with only microsatellite-stable tumors. WES revealed that, except one patient (6.5%), most synchronous cancers shared few variants in each patient (0.09%-0.36%). The concordance rates for BRAF, KRAS, NRAS, and PIK3CA, in synchronous cancers from each patient were 66.7%, 66.7%, 66.7%, and 55.6%, respectively.
Conclusion
Although synchronous cancers shared a mutated gene, the mutation subtypes differed. SCRCs exhibited 5.1% MSI status discordance rate and a high discordance rate in somatic mutational variants. As intertumoral heterogeneity may affect the targeted therapy response, molecular analysis of all tumors is recommended for patients with SCRCs.
  • 2,916 View
  • 100 Download
Close layer
Case Report
Five Cases Report of Solid Tumor Synchronously with Hematologic Malignancy
Yuehong Cui, Tianshu Liu, Yuhong Zhou, Yuan Ji, Yingyong Hou, Wen Jin, Yi Feng
Cancer Res Treat. 2012;44(1):63-68.   Published online March 31, 2012
DOI: https://doi.org/10.4143/crt.2012.44.1.63
AbstractAbstract PDFPubReaderePub
The reported incidence of synchronous multiple primary cancer (SMPC) is rare, and it is even less common to observe synchronous solid tumor with a hematological malignancy. We report five cases of solid tumor presented synchronously with hematological malignancy, all observed within a 2 year period at the oncology department of a university hospital in Shanghai, China. These individual cases included lung adenocarcinoma with chronic myelogenous leukemia, colon cancer with solitary plasmocytoma, gastric adenocarcinoma with diffuse large B cell non-Hodgkin's lymphoma, lung adenocarcinoma with multiple myeloma, and colon cancer with diffuse large B cell non-Hodgkin's lymphoma. It is challenging to therapeutically control the biological behavior of concurrent multiple primary tumors, and there is no standard treatment for such rare conditions. In this paper we discuss these five cases of SMPC and their treatments.

Citations

Citations to this article as recorded by  
  • A Case of Synchronous Primary Neoplasms of the Bladder and Skin
    Richa Choudhary, Shilpa P Tathe, Kirti Jaiswal
    Journal of GMC Nagpur.2026; 1(2): 86.     CrossRef
  • Unusual occurrence of solid tumors with hematological malignancies
    Rajarshi Aich, Ankita Sen, Abhishek Kumar, Dipkana Das, Subhajit Hajra, Anamika Mandal, Basab Bagchi
    Asian Journal of Oncology.2025; 11: 12.     CrossRef
  • A Rare Occurrence of Solid Gynecological Malignancy Synchronous with Hematological Malignancy: Rare Case and Review of Literature
    Rubi Gupta, Pariseema Dave, Bijal Patel, Remi Abdul Shukur
    Indian Journal of Medical and Paediatric Oncology.2024; 45(05): 439.     CrossRef
  • Synchronous multiple myeloma and lung adenocarcinoma: A clinical series
    Fang Ye, Huan Wang, Ningning Li, Aijun Liu, Wenming Chen
    Indian Journal of Pathology and Microbiology.2024; 67(2): 390.     CrossRef
  • Antiphospholipid Syndrome and Catastrophic Antiphospholipid Syndrome: A Comprehensive Review of Pathogenesis, Clinical Features, and Management Strategies
    Avinash Parepalli, Rajesh Sarode, Sunil Kumar, Manikanta Nelakuditi, M Jayanth Kumar
    Cureus.2024;[Epub]     CrossRef
  • Synchronous Head and Neck Squamous Cell Carcinoma and Hematologic Malignancies
    Pin-Ching Huang, Kai-Hua Lien, Cheng-Hsien Lin, Yi-Chun Liu
    Journal of Craniofacial Surgery.2024; 35(8): e812.     CrossRef
  • Co-existing squamous cell carcinoma and chronic myelomonocytic leukemia with ASXL1 and EZH2 gene mutations: A case report
    Lai-Jun Deng, Yang Dong, Mi-Mi Li, Chang-Gang Sun
    World Journal of Clinical Cases.2023; 11(15): 3643.     CrossRef
  • Metachronous Multiple Primary Carcinoma With Acute Promyelocytic Leukemia: 2 Cases Report and Literature Review
    Cong Wang, Yamei Shen, Yuxia Zhang, Fahui Guo, Qian Li, Huahua Zhang, Xueping Han, Haitao Zhao, Zilong Yang
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Synchronous or collision solid neoplasms and lymphomas: A systematic review of 308 case reports
    Rafael Parra-Medina, Franky Rocha, Juan Pablo Castañeda-González, Paula Moreno-Lucero, Luis Veloza, Alfredo E. Romero-Rojas
    Medicine.2022; 101(28): e28988.     CrossRef
  • Unusual Synchronous Association of Solid Tumors with Hematological Malignancies in Multiple Primary Cancers: Case Series and Literature Review
    Aboelkhair Al-Gahmi, Mohammed Alhuthali, Mohammad Alrehaili, Badee Baltow, Emad Tashkandi
    Case Reports in Oncology.2021; 14(1): 352.     CrossRef
  • Malignant melanoma: A double malignancy or second malignant neoplasm in a patient of acute lymphoblastic leukemia following therapy with a composite karyotype
    Pranita Mohanty, Nibedita Sahoo, Debasmita Das
    International Journal of Applied and Basic Medical Research.2020; 10(3): 218.     CrossRef
  • Clinical characteristics and prognosis associated with multiple primary malignant tumors in non-Hodgkin lymphoma patients
    Yanan Jiang, Zhaoyi Miao, Jinhuan Wang, Jing Chen, Yangyang Lv, Donghui Xing, Xiaofang Wang, Yafei Wang, Zeng Cao, Zhigang Zhao
    Tumori Journal.2019; 105(6): 474.     CrossRef
  • Diagnosis and Treatment of Synchronous Lymphoma and Digestive System Carcinoma: Report of Four Cases and Literature Review
    Jingshu Meng, Huaxiong Pan, Xiaoqian Li, Tao Liu, Zijian Liu, Qiuhui Li, Yin Xiao, Xinxiu Liu, Gang Wu, Fang Zhu, Liling Zhang
    Frontiers in Oncology.2019;[Epub]     CrossRef
  • Gastric mucosa-associated lymphoid tissue lymphoma in the context of multiple primary neoplasms
    Christian Ribas, Rosirê Wolffenbüttel Ribas, Fábio Antonio Tironi, Leonora Zozula Blind Pope
    Hematology, Transfusion and Cell Therapy.2018; 40(2): 189.     CrossRef
  • Synchronous Presentation of Two Extranodal Lymphomas: Follicular Lymphoma and Extranodal Marginal Zone Lymphoma of the Mucosa-Associated Lymphoid Tissue (MALToma)
    Yelda Dere, Volkan Karakuş, Özcan Dere, Nazan Özsan
    Acta Haematologica Polonica.2018; 49(1): 42.     CrossRef
  • One Pulmonary Lesion, 2 Synchronous Malignancies
    Masooma Aqeel, Nevin Uysal-Biggs, Timothy S. Fenske, Nagarjun Rao
    Journal of Investigative Medicine High Impact Case Reports.2018;[Epub]     CrossRef
  • Gastric carcinoma and acute myeloid leukemia: A case report of a double malignancy
    Supriya Pradhan, Mingma Sherpa
    Indian Journal of Pathology and Microbiology.2018; 61(4): 583.     CrossRef
  • Chronic myelomonocytic leukemia blast crisis in a patient with advanced non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors
    Hiroaki Ogata, Isamu Okamoto, Goichi Yoshimoto, Teppei Obara, Kayo Ijichi, Eiji Iwama, Taishi Harada, Koichi Akashi, Yoichi Nakanishi
    Respiratory Investigation.2017; 55(2): 181.     CrossRef
  • Diffuse large B-cell lymphoma in colon confounded by prior history of colorectal cancer: A case report and literature review
    YANLING REN, ZHILU CHEN, CHUANYONG SU, HONGYAN TONG, WENBIN QIAN
    Oncology Letters.2016; 11(2): 1493.     CrossRef
  • Lung cancer and concurrent or sequential lymphoma: Two case reports with hypersensitivity to bevacizumab and a review of the literature
    ALDO PEZZUTO, ALESSIO PIRAINO, SALVATORE MARIOTTA
    Oncology Letters.2015; 9(2): 604.     CrossRef
  • Leukemia cutis in a patient with acute monocytic leukemia diagnosed simultaneously with hepatocellular carcinoma: A case study
    DONG KEUN SEOK, SAE YOON KEE, SOON YOUNG KO, JUNG HWA LEE, HYE YOUNG KIM, IN SUN KIM, HEE YEON SEO
    Oncology Letters.2013; 6(5): 1319.     CrossRef
  • Coincidence of three solid tumors in a patient with multiple myeloma
    Muzaffer Keklik, Serdar Sivgin, Kemal Deniz, Halit Karaca, Olgun Kontas, Suleyman Balkanli, Celalettin Eroglu, Ummuhan Abdulrezzak, Gulfugan Kuzu, Leylagul Kaynar, Mustafa Cetin, Ali Unal, Bulent Eser
    Chinese Medical Journal.2013; 126(6): 1186.     CrossRef
  • 13,192 View
  • 102 Download
  • 22 Crossref
Close layer
Original Articles
Clinical Characteristics of Multiple Primary Colorectal Cancers
Joo Won Yoon, Seung Hyun Lee, Byung Kwon Ahn, Sung Uhn Baek
Cancer Res Treat. 2008;40(2):71-74.   Published online June 30, 2008
DOI: https://doi.org/10.4143/crt.2008.40.2.71
AbstractAbstract PDFPubReaderePub
Purpose

Although multiple primary colorectal cancer has been recognized as a significant clinical entity, its clinical and pathological features and its prognosis are still controversial. The purpose of this study was to clarify clinical and pathological features of multiple primary colorectal cancer.

Materials and Methods

Among 1669 patients who underwent surgery for primary colorectal cancer from January 1997 to June 2005, 26 patients (1.6%) with multiple primary colorectal cancer were identified. We reviewed clinical characteristics including diagnostic interval, lesions, operating methods, and TNM stage, and we defined the index lesion as the most advanced lesion among the synchronous lesions. For the purposes of the study, the colon and rectum were classified into three segments. The right-side colon included the appendix, cecum, ascending colon, hepatic flexure, and transverse colon, and the left-side colon included the splenic flexure, descending colon, and sigmoid colon.

Results

Of the 26 patients with multiple primary colorectal cancers, nineteen patients were male and seven patients were female, with a mean age of 61.5 years. Nineteen patients had synchronous colorectal cancers and seven patients had metachronous colorectal cancers. In the metachronous cases, the mean diagnostic interval was 36.8 months. The site of the first lesion in metachronous colorectal cancers was the right colon in five cases (71.4%) and the left colon in two cases (28.6%), and the site of the second lesion was the rectum in six cases (55.5%), the right colon in three cases (33.3%), and the left colon in one case. The TNM stage of the second lesions in the metachronous colorectal cancers was stage II in four cases (57.1%), stage III in one case (14.3%), and stage IV in one case (14.3%). For the synchronous colorectal cancers, the operation methods were single-segment resection combined with endoscopic mucosal resection in five cases (26.3%), single-segment resection alone in six cases, two-segment resection in six cases, and total colectomy in two cases.

Conclusion

In metachronous colorectal cancers, the secondary lesions were later-stage cancer. Therefore, careful postoperative follow-up is necessary for patients who have undergone surgery for colorectal cancers. Further study of therapeutic modalities is important for synchronous colorectal cancers.

Citations

Citations to this article as recorded by  
  • Case Report: Unique immunotherapy response in a patient with metachronous colorectal cancer not associated with Lynch Syndrome
    Nithya Krishnamurthy, Deirdre Cohen
    Frontiers in Oncology.2025;[Epub]     CrossRef
  • A nomogram for predicting the overall survival in rectal cancer patients after total neoadjuvant therapy
    Z. Liu, M. He, X. Wang
    Techniques in Coloproctology.2024;[Epub]     CrossRef
  • Developing prognostic nomograms to predict overall survival and cancer-specific survival in synchronous multiple primary colorectal cancer based on the SEER database
    Xiangyu Zhang, Yanpeng Hu, Kai Deng, Wanbo Ren, Jie Zhang, Cuicui Liu, Baoqing Ma
    Journal of Cancer Research and Clinical Oncology.2023; 149(15): 14057.     CrossRef
  • A Pathomimetic Colorectal Tumor‐on‐a‐Chip for In Vitro Reconstitution of the Primary Colorectal Cancer
    Zhangcai Liu, Ziming Yu, Jianpei Dong, Deyu Yang, Juanhua Li, Zhen He, Jianhua Zhou, Lu Huang
    Advanced Materials Technologies.2023;[Epub]     CrossRef
  • The incidence of second primary cancer in male and female patients with initial colorectal cancer: a SEER population-based study
    Yanyan Chen, Chao Han, Yadi Huang, Chao Liu, Siqi Sheng, Linlin Ji, Jialong Zhu, Gongbo Fu, Xiaobei Mao, Mengxi Huang, Zengjie Lei, Xiaoyuan Chu
    European Journal of Cancer Prevention.2022; 31(5): 430.     CrossRef
  • Tissue Displacement Versus Two Primary Colorectal Carcinomas? A Case Report on the Utility of Comparative Sequencing
    Ellie S. Hong, Wells A. Messersmith, Hazem Hammad, Toby C. Cornish, Dara L. Aisner
    JCO Precision Oncology.2022;[Epub]     CrossRef
  • Do Patients with Second Primary Colorectal Cancer Hold the Similar Prognosis and Therapeutic Benefits as Those with Initial Primary Colorectal Cancer?
    Quan Chen, Shan Zhao, Yongxi Song, Peng Gao, Jingxu Sun, Xiaowan Chen, Yu Sun, Zhenning Wang
    BioMed Research International.2018; 2018: 1.     CrossRef
  • KRAS mutation status impacts diagnosis and treatment decision in a patient with two colon tumours: a case report
    Xiaodong Li, G Pezeshkpour, Ryan T Phan
    Journal of Clinical Pathology.2015; 68(1): 83.     CrossRef
  • Two Synchronous Colonic Adenocarcinomas, a Gastric Schwannoma and a Mucinous Neoplasm of the Appendix: a Case Report
    Diogo Sousa, Miguel Allen, Alda Pinto, Andreia Ferreira, Ana Cruz, Diogo Marinho, Pierpaolo Cusati, José Augusto Martins
    Journal of Gastrointestinal Cancer.2015; 46(3): 304.     CrossRef
  • KRAS and BRAF genotyping of synchronous colorectal carcinomas
    RICCARDO GIANNINI, CRISTIANA LUPI, FOTIOS LOUPAKIS, ADELE SERVADIO, CHIARA CREMOLINI, ELISA SENSI, MASSIMO CHIARUGI, CARLOTTA ANTONIOTTI, FULVIO BASOLO, ALFREDO FALCONE, GABRIELLA FONTANINI
    Oncology Letters.2014; 7(5): 1532.     CrossRef
  • Population-based data from the Swedish Colon Cancer Registry
    K Kodeda, L Nathanaelsson, B Jung, H Olsson, P Jestin, A Sjövall, B Glimelius, L Påhlman, I Syk
    British Journal of Surgery.2013; 100(8): 1100.     CrossRef
  • Metachronous carcinomas in colorectum and its clinicopathological significance
    Alfred King-Yin Lam, Vinod Gopalan, Robert Carmichael, Petra Gertraud Buettner, Melissa Leung, Robert Smith, Cu-Tai Lu, Yik-Hong Ho, Simon Siu
    International Journal of Colorectal Disease.2012; 27(10): 1303.     CrossRef
  • Metastasis at the Colostomy Site: A Rare Case Report
    Y.-H. Kuo, C.-C. Chin, K.-F. Lee
    Japanese Journal of Clinical Oncology.2012; 42(8): 753.     CrossRef
  • Total colectomy as part of primary cytoreductive surgery in advanced Müllerian cancer
    Yong Jung Song, Myong Cheol Lim, Sokbom Kang, Sang-Soo Seo, Ji Won Park, Hyo Seong Choi, Sang-Yoon Park
    Gynecologic Oncology.2009; 114(2): 183.     CrossRef
  • 11,194 View
  • 64 Download
  • 14 Crossref
Close layer
Characteristics of Synchronous Cancers in Gastric Cancer Patients
Ja Seong Bae, Jun Ho Lee, Keun Won Ryu, Young Woo Kim, Jae Moon Bae
Cancer Res Treat. 2006;38(1):25-29.   Published online February 28, 2006
DOI: https://doi.org/10.4143/crt.2006.38.1.25
AbstractAbstract PDFPubReaderePub
Purpose

The primary objective of the current study was to investigate the characteristics of synchronous cancers in gastric cancer patients.

Materials and Methods

We analyzed the 2,237 patients who were diagnosed between December 2000 and December 2003 with gastric cancer and synchronous cancers of organs other than the stomach.

Results

73 (3.3%) of a total of 2,237 gastric cancer patients had synchronous primary cancers. Among these 73 patients, 71 had one synchronous cancer, and two patients had double synchronous cancers. Colorectal cancer (26 patients, 34.7%) was the most frequently encountered synchronous cancer, followed by cancer of the lung (16 patients, 21.3%), esophagus (13 patients, 17.2%), and liver (8 patients, 10.7%). Synchronous cancers were detected with increased frequency in the elderly, in the patients with multiple gastric cancers, in the patients with differentiated gastric cancer, and in the patients with early gastric cancer, as determined on univariate analysis, but the differentiation of gastric cancers was the only risk factor for synchronous cancers on the multivariate analysis.

Conclusions

The differentiation of gastric cancer cells may be a risk factor for synchronous cancers in gastric cancer patients. Careful surveillance by the physician for synchronous cancer is warranted for the patients suffering from gastric cancer.

Citations

Citations to this article as recorded by  
  • Rare metastasis of the urinary bladder from esophageal squamous cell carcinoma: a case report
    Chunlei Zhang, Dehui Chang, Dongxing Wang, Jiale Zuo, Zhigang Cao
    Frontiers in Oncology.2025;[Epub]     CrossRef
  • Synchronous Triple Primary Gastrointestinal Tract Malignancies: A Case Report
    Hyeon Min Rim, Young Min Rah, Ju Seok Kim
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2025; 25(4): 381.     CrossRef
  • Synchronous Triple Malignancy of Esophagus, Pancreas, and Pyriform Sinus: A Prima Facie Report
    Sekhar Saha, Varun Goel, Arnab Chakraborty, Vineet Talwar
    Indian Journal of Surgical Oncology.2024; 15(S2): 349.     CrossRef
  • Synchronous Gastric and Colonic Adenocarcinoma: A Case Report With its Molecular Implications
    Lakshmipriya V, Sarah Grace Priyadarshini , Neha Agarwal, Padmapriya B S
    Cureus.2024;[Epub]     CrossRef
  • Triple metachronous primary cancer of uterus, colon, and breast cancer
    Guanqiao Li, Jia Yao, Tangna Wu, Yaxiong Chen, Zhenping Wang, Yiming Wang, Fen Wang, Rui Zhong, Shiping Yang
    Medicine.2020; 99(34): e21764.     CrossRef
  • Gastric cancer and intrahepatic cholangiocarcinoma
    Alex Emmanuel Elobu, Ashok Thorat, Vianney Kweyamba, Rakesh Rai
    Formosan Journal of Surgery.2019; 52(3): 107.     CrossRef
  • Clinicopathologic characteristics and survival rate in patients with synchronous or metachronous double primary colorectal and gastric cancer
    Ji-Hyeon Park, Jeong-Heum Baek, Jun-Young Yang, Won-Suk Lee, Woon-Kee Lee
    Korean Journal of Clinical Oncology.2018; 14(2): 83.     CrossRef
  • Can positron emission tomography detect colorectal adenomas and cancers?
    Kimihiro Igarashi, Kinichi Hotta, Kenichiro Imai, Yuichiro Yamaguchi, Sayo Ito, Noboru Kawata, Masaki Tanaka, Naomi Kakushima, Kohei Takizawa, Hiroyuki Matsubayashi, Masahiro Endo, Kouiku Asakura, Takuma Oishi, Tadakazu Shimoda, Hiroyuki Ono
    Journal of Gastroenterology and Hepatology.2017; 32(3): 602.     CrossRef
  • Triple synchronous primary malignancies: a rare occurrence
    Heather Katz, Hassaan Jafri, Linda Brown, Toni Pacioles
    BMJ Case Reports.2017; 2017: bcr-2017-219237.     CrossRef
  • A Concurrence of Adenocarcinoma with Micropapillary Features and Composite Glandular-Endocrine Cell Carcinoma in the Stomach
    Ji-Hoon Kim, Dae-Woon Eom, Cheon-Soo Park, Jae-Young Kwak, Eun-Hwa Park, Jin-Ho Kwak, Hyuk-Jae Jang, Kun-Moo Choi, Myung-Sik Han
    Journal of Gastric Cancer.2016; 16(4): 266.     CrossRef
  • Synchronous triple primary cancers occurring in the stomach, kidney, and thyroid
    Sung Jin Oh, Dong Sik Bae, Byoung Jo Suh
    Annals of Surgical Treatment and Research.2015; 88(6): 345.     CrossRef
  • Risk factors for double primary malignancies and their clinical implications in patients with sporadic gastric cancer
    I. Cho, J.Y. An, I.G. Kwon, Y.Y. Choi, J.H. Cheong, W.J. Hyung, S.H. Noh
    European Journal of Surgical Oncology (EJSO).2014; 40(3): 338.     CrossRef
  • Concurrent Robot-Assisted Distal Gastrectomy and Partial Nephrectomy for Synchronous Early Gastric Cancer and Renal Cell Carcinoma: An Initial Experience
    Jieun Kim, Su Mi Kim, Jeong Eun Seo, Min Gew Choi, Jun Ho Lee, Tae Sung Sohn, Sung Kim, Jae Moon Bae, Seong Il Seo
    Journal of Gastric Cancer.2014; 14(3): 211.     CrossRef
  • Concurrent Robot-Assisted Distal Gastrectomy and Partial Nephrectomy for Synchronous Early Gastric Cancer and Renal Cell Carcinoma: An Initial Experience
    Jieun Kim, Su Mi Kim, Jeong Eun Seo, Min Gew Choi, Jun Ho Lee, Tae Sung Sohn, Sung Kim, Jae Moon Bae, Seong Il Seo
    Journal of Gastric Cancer.2014; 14(3): 211.     CrossRef
  • Management of gastric epithelial neoplasia in patients requiring esophagectomy for esophageal cancer
    H. I., G. H. Kim, D. Y. Park, Y. D. Kim, B. E. Lee, D. Y. Ryu, D. U. Kim, G. A. Song
    Diseases of the Esophagus.2013; 26(6): 603.     CrossRef
  • Synchronous lung and gastric cancers successfully treated with carboplatin and pemetrexed: a case report
    Takashi Sato, Koji Tomaru, Tomoko Koide, Makoto Masuda, Masaki Yamamoto, Naoki Miyazawa, Yoshiaki Inayama, Takeshi Kaneko, Yoshiaki Ishigatsubo
    Journal of Medical Case Reports.2012;[Epub]     CrossRef
  • Synchronous primary gastric cancer and renal cell carcinoma: A case report and literatures review
    Kung-Ning Hu, Wei-Hong Lai, Po-Tsang Tseng, Wen-Ching Wang, Kun-Hung Shen
    Urological Science.2012; 23(1): 28.     CrossRef
  • Synchronous multifocal early gastric cancers and rectal adenocarcinoma: Lesson learnt from image‐enhanced endoscopy
    Boon Eu Andrew KWEK, Tiing Leong ANG, Kwong Ming FOCK, Eng Kiong TEO
    Journal of Digestive Diseases.2011; 12(3): 226.     CrossRef
  • Clinical improvement of membranous nephropathy after endoscopic resection of double early gastrointestinal cancers
    Satoshi Matsui, Hiroko Tsuji, Yukinobu Takimoto, Shinji Ono
    Clinical and Experimental Nephrology.2011; 15(2): 285.     CrossRef
  • Microsatellite Instability Is Associated with the Clinicopathologic Features of Gastric Cancer in Sporadic Gastric Cancer Patients
    Shin Hyuk Kim, Byung Kyu Ahn, Young Su Nam, Joo Youn Pyo, Young Ha Oh, Kang Hong Lee
    Journal of Gastric Cancer.2010; 10(4): 149.     CrossRef
  • Second primary cancers in patients with gastric cancer
    Oktay Buyukasik, Ahmet Hasdemir, Yusuf Gulnerman, Cavit Col, Ozgur Ikiz
    Radiology and Oncology.2010;[Epub]     CrossRef
  • 11,333 View
  • 58 Download
  • 21 Crossref
Close layer
Case Report
Three Cases of Synchronous Solid Tumor and Multiple Myeloma
Sang Hoon Ji, Joon Oh Park, Jeeyun Lee, Mi Jung Oh, Do Hyoung Lim, Byeong-Bae Park, Keun Woo Park, Se-Hoon Lee, Kihyun Kim, Won Seog Kim, Chul Won Jung, Young Suk Park, Young-Hyuck Im, Won Ki Kang, Mark H Lee, Keunchil Park
Cancer Res Treat. 2004;36(5):338-340.   Published online October 31, 2004
DOI: https://doi.org/10.4143/crt.2004.36.5.338
AbstractAbstract PDFPubReaderePub

The association between a multiple myeloma and a secondary solid tumor is not well established. Some reports showed an increased risk of secondary solid neoplasms in multiple myeloma patients, but others have not. Three cases of the synchronous occurrence of multiple myelomas and solid tumors, namely, a small cell carcinoma of the lung, an adenocarcinoma of the colon and a squamous carcinoma of the pyriform sinus were experienced at our hospital. Therefore, herein is reported the clinical courses and treatment results. The stage of multiple myeloma was Durie-Salmon stage I in all of three cases; therefore, the solid tumors were treated as a primary target because the prognosis of early stage multiple myeloma is generally better than that of advanced solid tumor, while a smoldering or stage I myeloma do not need primary therapy until progression of the multiple myeloma. Two patients died of their solid tumors, but one patient is alive.

Citations

Citations to this article as recorded by  
  • Three-year progression-free survival of a patient with concomitant mucinous adenocarcinoma of the colon with peritoneal dissemination and multiple myeloma who received lenalidomide: a case report
    Koki Tamai, Hajime Hirose, Yo Akazawa, Yukihiro Yoshikawa, Masatoshi Nomura, Hiroshi Takeyama, Masahiro Tokunaga, Mitsuyoshi Tei, Shu Okamura, Yusuke Akamaru
    Surgical Case Reports.2024;[Epub]     CrossRef
  • The importance of oncological alertness in the differential diagnosis of inflammatory changes in the lungsdetected as a result of differential diagnosis of pneumonia
    M. F. Petrukhnova, O. O. Voronkova, O. E. Buyanova, O. N. Antyufeeva, A. E. Kamalova, M. V. Kozhevnikova, I. S. Ilgisonis, Yu. N. Belenkov
    Meditsinskiy sovet = Medical Council.2024; (9): 100.     CrossRef
  • Synchronous multiple myeloma and lung adenocarcinoma: A clinical series
    Fang Ye, Huan Wang, Ningning Li, Aijun Liu, Wenming Chen
    Indian Journal of Pathology and Microbiology.2024; 67(2): 390.     CrossRef
  • Simultaneous multiple myeloma and non‑small cell lung carcinoma: A case report and review of the literature
    Huan-Huan Dong, Jing Li, Lin Kang, Qiang Wei, Yan Li
    Oncology Letters.2022;[Epub]     CrossRef
  • Rapid progression of gastric cancer with liver metastasis after discontinuation of lenalidomide in a patient with concurrent multiple myeloma
    Naoto Ujiie, Yoshitaka Enomoto, Naruhito Takido, Yasushi Kawaharada, Masashi Zuguchi, Yosuke Kubota
    International Journal of Surgery Case Reports.2021; 81(C): 105834.     CrossRef
  • Bortezomib combined with lenalidomide as the first-line treatment for the rare synchronous occurrence of multiple myeloma and pulmonary adenocarcinoma
    Wenli Zuo, Xinghu Zhu, Jingke Yang, Zhenyang Mei, Mei Deng, Quande Lin, Yongping Song, Qingsong Yin
    Medicine.2017; 96(1): e5787.     CrossRef
  • Drastic Response to Nivolumab in a Case Demonstrating a Rapid Recurrence of Pulmonary Pleomorphic Carcinoma That Developed After Chemotherapy for Comorbid Myeloma Kidney
    Aya Yamamoto, Takashi Iwata, Koji Hashimoto
    Haigan.2017; 57(7): 849.     CrossRef
  • Challenges in managing a patient with multiple primary malignancies
    Nataliya Mar, David Askin, Jerry George, Colette Spaccavento, Robert Graham, Lynn Ratner
    Community Oncology.2012; 9(12): 377.     CrossRef
  • ¿Asociación entre colangiocarcinoma y mieloma múltiple?
    Laura Gómez-Escolar Viejo, Gema Soler Sala, Vanessa Castaño Giraldo, José María Palazón Azorín, Miguel Pérez-Mateo Regadera
    Gastroenterología y Hepatología.2008; 31(6): 402.     CrossRef
  • Synchronous Presentation of Multiple Myeloma and Lung Cancer
    Rishu Agarwal, Ritu Gupta, Archana Bhaskar, Atul Sharma, Sanjay Thulkar, Lalit Kumar
    Journal of Clinical Oncology.2008; 26(35): 5814.     CrossRef
  • 12,018 View
  • 54 Download
  • 10 Crossref
Close layer
Original Articles
Clinicopathologic Features of Multiple Synchronous Gastric Cancer
Jin Bok Kim, Min Kyu Choi, Joo Ho Lee, Seung Ik Ahn, Soo Jin Kim, Hang Jong Yu, Han Kwang Yang
J Korean Cancer Assoc. 1998;30(4):652-659.
AbstractAbstract PDF
PURPOSE
With recent advances of diagnostic methods and precise histopathologic examination, the incidence of synchronous multiple gastric cancer has increased. The purpose of this study was to evaluate the clinicopathologic features of patients with synchronous multiple gastric cancer.
MATERIALS AND METHODS
We reviewed the clinicopathologic features of 189 patients with synchronous multiple gastric cancer out of 8,101 patients who underwent gastric resections for gastric cancers during 20 years from January 1977 to December 1996 at the Department of Surgery, Seoul National University Hospital, and compared them with single gastric cancer patients. The clinicopathologic features evaluated were age, sex, diagnostic method and accuracy, location of lesions, tumor size, histologic differentiation, Lauren classification, macroscopic classification, depth of invasion, lymph node metastasis, TNM stage, and type of operation and prognosis.
RESULTS
The overall incidence of multiple synchronous gastric cancer was 2.33%. The mean age was 57.2 years old (27~84) and peak incidence was sixth decade. Male was predominant, that the sex ratio was 3.9: 1. Multiple gastric cancer was more frequent in old age, male and early gastric cancer patients. The number of lesions ranged from 2 to 5. In most cases, the lesions were located in lower two-thirds of the stomach. However, in 13 cases, lesions were located in both upper one-third and lower one-third. Only 33.3% of multiple cancer was diagnosed preoperatively, with the diagnostic accuracy of GFS was 30.0% and that of UGIS 26.1%. The most frequently missed lesions at preoperative examination were located in upper third of stomach, posterior wall of middle third and anterior wall of lower third of stomach. The most common macroscopic type was Borrmann type III (54.5%) in advanced lesions and type IIc (47.0%) in early lesions. Regarding the histologic differentiation, 58.7% of the cases were of the same differentiation and the cases composed of well differentiated adenocarcinomas were most common. According to the Laurens classification, 66.7% of lesions were intestinal type. As to the progression of the lesions, all lesions were early cancers in 75 cases, advanced cancers in 39 cases and advanced cancers were coexist with early cancers in 75 cases. Lymph node metastasis was less frequent than in single gastric cancer. Total gastrectomy was performed more frequently in multiple cancer patients than in single gastric cancer patients. The 5-year survival rate of patients with multiple gastric cancer was 70.2%, which was not significantly different from that of patients with single gastric cancer.
CONCLUSIONS
Surgeons must keep in mind the possibility of multiple gastric lesions. More careful preoperative and intraoperative examination is mandatory to detect the possible accessory lesions, and postoperative periodic follow-up is necessary to detect any missed lesions, especially in the old age, male and early gastric cancer patients.
  • 4,054 View
  • 33 Download
Close layer
Multiple Primary Cancers in the Stomach and Different Organs
Byung Moo Jeon, Nam Il Kim, Jung Soo Kim, Hae Myung Jeon, Seung Jin Yoo, Jae Sung Kim, Sung Hoon Kim, Eun Jung Lee
J Korean Cancer Assoc. 1996;28(2):394-404.
AbstractAbstract PDF
Multiple primary malingnant tumors are not rare recently with the development of the diagnostic methods. Billroth first documented the occurence of more than one independent cancer developing in the same patient a century ago and stated that each tumor must have an independent histologic appearences and must arise in different localities. Some studies have been reported on the possible relationship between multiple primary malignancies and excessive exposure to sunlight, occupational exposure, ionizing radiation, role of oncogenic viruses, tabacco usage, heavy alcohol consumption, and/or familial tendency, genetic factors. Many studies indicate that the prognosis of synchronous primary tumors is poorer than that of single tumor. The first case is the gastric cancer combined with chondrosarcoma of rib. Neoplasms of the ribes are rare and synchronous primary tumors are more rare. Most primary bony chest wall neoplasms are malignant, and chondrosarcoma is the most common malignant tumor in this location. The etiology of chondrosarcoma is unknown. Definitive diagnosis of chondrosarcoma can be made pathologically. The characteristic natural history of chest wall chondrosarcoma is slow growth and high local recurrence. Most tumors of the sternum require wide resection and reconstruction procedures, with potentially serious postoperative problems. The second case is the early gastric cancer combined synchronous cholangiocarcinoma that rarely associated with hepatolithiasis. It was nearly impossible to detect the malignant lesions preoperatively. And then patients with a long history of recurrent cholangitis due to hepatolithiasis should be admitted to a hospital, and precise examinations, including abdominal sonography, CT, cholangiography, aspiration cytology, choledochoscopy, frozen section biopsy pre-and intraoperatively, should be performed in order to rule out a coexisting cholangiocarcinoma especially in the operative findings of suspected malignant lesion. We experienced a 66 year-old man who was diagnosed stomach cancer with chondrosarcoma of ribs and a 63 year-old man who had early gastric cancer combined synchronous cholangiocarcinoma associated with hepatolithiasis. The patients underwent wide resection of tumor mass with Billroth-II suntotal gastrectomy. The patients had uneventful postoperative courses and discharged with adjuvant chemotheraphy.
  • 3,296 View
  • 17 Download
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP